Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised control... by Lennox, Jeffrey L, Prof, DeJesus, Edwin, MD, Lazzarin, Adriano, Prof, Pollard, Richard B, Prof, Madruga, Jose Valdez Ramalho, MD, Berger, Daniel S, MD, Zhao, Jing, PhD, Xu, Xia, PhD, Williams-Diaz, Angela, BS, Rodgers, Anthony J, MS, Barnard, Richard JO, PhD, Miller, Michael D, PhD, DiNubile, Mark J, MD, Nguyen, Bach-Yen, MD, Leavitt, Randi, MD, Sklar, Peter, Dr

Get full text

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial by Eron, Joseph J, Prof, Rockstroh, Jürgen K, MD, Reynes, Jacques, Prof, Andrade-Villanueva, Jaime, MD, Ramalho-Madruga, Jose Valdez, MD, Bekker, Linda-Gail, MD, Young, Benjamin, MD, Katlama, Christine, MD, Gatell-Artigas, Jose Maria, MD, Arribas, Jose R, MD, Nelson, Mark, MD, Campbell, Havilland, BS, Zhao, Jing, PhD, Rodgers, Anthony J, MS, Rizk, Matthew L, PhD, Wenning, Larissa, PhD, Miller, Michael D, PhD, Hazuda, Daria, PhD, DiNubile, Mark J, MD, Leavitt, Randi, MD, Isaacs, Robin, MD, Robertson, Michael N, MD, Sklar, Peter, MD, Nguyen, Bach-Yen, Dr

Get full text